SCHEMBL3653273

SCHEMBL3653273

O=C(O)C1=NN=C(C(=O)O)NN1

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 3/20 0.32
DAO P14920 1/20 0.32
NOTUM Q6P988 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3711708 0.77
SCHEMBL3658723 0.75
SCHEMBL5461236 0.69
Potassium SCHEMBL30723002 0.67
SCHEMBL21621209 0.65
SCHEMBL30910409 0.53
Bicarbonate SCHEMBL28231491 0.53 CA1 (0.83)
Bicarbonate SCHEMBL11793521 0.53
Bicarbonate SCHEMBL11793746 0.53
Bicarbonate SCHEMBL21305 0.53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101925660-A Organosilane coating composition and use thereof DUBLIN INST OF TECHNOLOGY 2010-12-22 CN claimed
EP-2220176-B1 SOL-GEL COATING COMPOSITIONS AND THEIR PROCESS OF PREPARATION DUBLIN INSTITUTE OF TECH INTELLECTUAL PROPERTY LTD (IE) 2018-09-19 EP disclosed
US-20100330380-A1 Organosilane Coating Compositions and Use Thereof DUBLIN CITY UNIVERSITY (IE) 2010-12-30 US disclosed
US-20100330380-A1 Organosilane Coating Compositions and Use Thereof DUBLIN CITY UNIVERSITY (IE) 2010-12-30 US disclosed
US-20100330380-A1 Organosilane Coating Compositions and Use Thereof DUBLIN CITY UNIVERSITY (IE) 2010-12-30 US disclosed
CN-101925660-A Organosilane coating composition and use thereof DUBLIN INST OF TECHNOLOGY 2010-12-22 CN disclosed
EP-2220176-A2 SOL-GEL COATING COMPOSITIONS AND THEIR PROCESS OF PREPARATION Dublin Institute of Technology Intellectual Property Ltd (IE) 2010-08-25 EP disclosed
WO-2009069111-A2 SOL-GEL COATING COMPOSITIONS AND THEIR PROCESS OF PREPARATION DUBLIN INSTITUTE OF TECHNOLOGY (IE) 2009-06-04 WO disclosed
US-7329651-B2 Cannabimimetic ligands UNIVERSITY OF CONNECTICUT (US) 2008-02-12 US disclosed
US-20040077649-A1 Novel cannabimimetic ligands CONNECTICUT, UNIVERSITY OF 2004-04-22 US disclosed
US-6588797-B1 Air bag; inorganic salt oxidizer and a fuel; fuel is3-R1-6-R2-1,2,4,5-tetrazine-1,4, dioxide TRW INC. 2003-07-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040077649-A1 Novel cannabimimetic ligands CNR2, CNR1, GPR18 HCAR2 236/4885DAO 3135/4885NOTUM 689/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.